Adaptor Protein Abelson Interactor 1 in Homeostasis and Disease

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2024 Oct 1

PMID 39354505

Authors

Max Petersen

Pat Dubielecka

Affiliations

Soon will be listed here.

Abstract

Dysregulation of Abelson interactor 1 (ABI1) is associated with various states of disease including developmental defects, pathogen infections, and cancer. ABI1 is an adaptor protein predominantly known to regulate actin cytoskeleton organization processes such as those involved in cell adhesion, migration, and shape determination. Linked to cytoskeleton via vasodilator-stimulated phosphoprotein (VASP), Wiskott-Aldrich syndrome protein family (WAVE), and neural-Wiskott-Aldrich syndrome protein (N-WASP)-associated protein complexes, ABI1 coordinates regulation of various cytoplasmic protein signaling complexes dysregulated in disease states. The roles of ABI1 beyond actin cytoskeleton regulation are much less understood. This comprehensive, protein-centric review describes molecular roles of ABI1 as an adaptor molecule in the context of its dysregulation and associated disease outcomes to better understand disease state-specific protein signaling and affected interconnected biological processes.

References

Stanton R, Prodhomme V, Purbhoo M, Moore M, Aicheler R, Heinzmann M . HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. Cell Host Microbe. 2014; 16(2):201-214. PMC: 4150922. DOI: 10.1016/j.chom.2014.07.005. View

Lin C, Yu B, Zhang M, Chen Y, Li L, Zhao D . Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance. Front Genet. 2020; 11:522831. PMC: 7705250. DOI: 10.3389/fgene.2020.522831. View

Wang T, Cleary R, Wang R, Tang D . Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction. J Biol Chem. 2013; 288(28):20713-22. PMC: 3711334. DOI: 10.1074/jbc.M112.439877. View

Zhang J, Adrian F, Jahnke W, Cowan-Jacob S, Li A, Iacob R . Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature. 2010; 463(7280):501-6. PMC: 2901986. DOI: 10.1038/nature08675. View

Rogers E, Allred S, Peifer M . Abelson kinase's intrinsically disordered region plays essential roles in protein function and protein stability. Cell Commun Signal. 2021; 19(1):27. PMC: 7905622. DOI: 10.1186/s12964-020-00703-w. View

McShea M, Schmidt K, Dubuke M, Baldiga C, Sullender M, Reis A . Abelson interactor-1 (ABI-1) interacts with MRL adaptor protein MIG-10 and is required in guided cell migrations and process outgrowth in C. elegans. Dev Biol. 2012; 373(1):1-13. PMC: 4344190. DOI: 10.1016/j.ydbio.2012.09.017. View

Sun X, Li Y, Yu W, Wang B, Tao Y, Dai Z . MT1-MMP as a downstream target of BCR-ABL/ABL interactor 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration. Leukemia. 2007; 22(5):1053-6. PMC: 2430881. DOI: 10.1038/sj.leu.2404990. View

Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H . Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 1993; 53(23):5624-8. View

Wang R, Cleary R, Wang T, Li J, Tang D . The association of cortactin with profilin-1 is critical for smooth muscle contraction. J Biol Chem. 2014; 289(20):14157-69. PMC: 4022883. DOI: 10.1074/jbc.M114.548099. View

10.

Garcia-Cuellar M, Schreiner S, Birke M, Hamacher M, Fey G, Slany R . ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+. Oncogene. 2000; 19(14):1744-51. DOI: 10.1038/sj.onc.1203506. View

11.

Sekino S, Kashiwagi Y, Kanazawa H, Takada K, Baba T, Sato S . The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex. Cell Commun Signal. 2015; 13:41. PMC: 4589964. DOI: 10.1186/s12964-015-0119-5. View

12.

Giuliani C, Troglio F, Bai Z, Patel F, Zucconi A, Malabarba M . Requirements for F-BAR proteins TOCA-1 and TOCA-2 in actin dynamics and membrane trafficking during Caenorhabditis elegans oocyte growth and embryonic epidermal morphogenesis. PLoS Genet. 2009; 5(10):e1000675. PMC: 2744924. DOI: 10.1371/journal.pgen.1000675. View

13.

Rak M, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S . Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency. J Virol. 2018; 92(20). PMC: 6158428. DOI: 10.1128/JVI.00919-18. View

14.

Wang K, Liu Y, Xu C, Liu X, Luo X . Family-based association analysis of NAV2 gene with the risk and age at onset of Alzheimer's disease. J Neuroimmunol. 2017; 310:60-65. PMC: 6167010. DOI: 10.1016/j.jneuroim.2017.06.010. View

15.

Worthmuller J, Ruegg C . The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication. Int J Mol Sci. 2020; 21(23). PMC: 7730291. DOI: 10.3390/ijms21239107. View

16.

Shi J, Casanova J . Invasion of host cells by Salmonella typhimurium requires focal adhesion kinase and p130Cas. Mol Biol Cell. 2006; 17(11):4698-708. PMC: 1635395. DOI: 10.1091/mbc.e06-06-0492. View

17.

Reiske H, Kao S, CARY L, Guan J, Lai J, Chen H . Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J Biol Chem. 1999; 274(18):12361-6. DOI: 10.1074/jbc.274.18.12361. View

18.

Juang J, Hoffmann F . Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity. Oncogene. 1999; 18(37):5138-47. DOI: 10.1038/sj.onc.1202911. View

19.

Ly K, Casanova J . Abelson tyrosine kinase facilitates Salmonella enterica serovar Typhimurium entry into epithelial cells. Infect Immun. 2008; 77(1):60-9. PMC: 2612273. DOI: 10.1128/IAI.00639-08. View

20.

Anderson C, Zhou S, Sawin E, Horvitz H, Hurwitz M . SLI-1 Cbl inhibits the engulfment of apoptotic cells in C. elegans through a ligase-independent function. PLoS Genet. 2012; 8(12):e1003115. PMC: 3521709. DOI: 10.1371/journal.pgen.1003115. View